Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1990 May-Jun;63(3):209–214.

Tourette's disorder and associated complex behaviors: a case report.

C J McDougle 1, S M Southwick 1, R M Rohrbaugh 1
PMCID: PMC2589286  PMID: 2238716

Abstract

A case of a man with Tourette's disorder associated with obsessive-compulsive disorder, multiple sexual paraphilias, and aggressive behavior is described. Treatment with haloperidol led to improvement in the characteristic tics of Tourette's disorder as well as to improvement in these three complex-associated behaviors. After haloperidol was discontinued, an exacerbation of tics and the associated behaviors occurred.

Full text

PDF
209

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antelman S. M., Caggiula A. R. Norepinephrine-dopamine interactions and behavior. Science. 1977 Feb 18;195(4279):646–653. doi: 10.1126/science.841304. [DOI] [PubMed] [Google Scholar]
  2. Cohen D. J., Shaywitz B. A., Young J. G., Carbonari C. M., Nathanson J. A., Lieberman D., Bowers M. B., Jr, Maas J. W. Central biogenic amine metabolism in children with the syndrome of chronic multiple tics of Gilles de la Tourette: norepinephrine, serotonin, and dopamine. J Am Acad Child Psychiatry. 1979 Spring;18(2):320–341. doi: 10.1016/s0002-7138(09)61046-3. [DOI] [PubMed] [Google Scholar]
  3. Comings D. E. A controlled study of Tourette syndrome. VII. Summary: a common genetic disorder causing disinhibition of the limbic system. Am J Hum Genet. 1987 Nov;41(5):839–866. [PMC free article] [PubMed] [Google Scholar]
  4. Comings D. E., Comings B. G. A case of familial exhibitionism in Tourette's syndrome successfully treated with haloperidol. Am J Psychiatry. 1982 Jul;139(7):913–915. doi: 10.1176/ajp.139.7.913. [DOI] [PubMed] [Google Scholar]
  5. Devinsky O. Neuroanatomy of Gilles de la Tourette's syndrome. Possible midbrain involvement. Arch Neurol. 1983 Aug;40(8):508–514. doi: 10.1001/archneur.1983.04210070048013. [DOI] [PubMed] [Google Scholar]
  6. Eldridge R., Sweet R., Lake R., Ziegler M., Shapiro A. K. Gilles de la Tourette's syndrome: clinical, genetic, psychologic, and biochemical aspects in 21 selected families. Neurology. 1977 Feb;27(2):115–124. doi: 10.1212/wnl.27.2.115. [DOI] [PubMed] [Google Scholar]
  7. Factor S. A., Sanchez-Ramos J. R., Weiner W. J. Cocaine and Tourette's syndrome. Ann Neurol. 1988 Apr;23(4):423–424. doi: 10.1002/ana.410230431. [DOI] [PubMed] [Google Scholar]
  8. Feinberg M., Carroll B. J. Effects of dopamine agonists and antagonists in Tourette's disease. Arch Gen Psychiatry. 1979 Aug;36(9):979–985. doi: 10.1001/archpsyc.1979.01780090065007. [DOI] [PubMed] [Google Scholar]
  9. Frankel M., Cummings J. L., Robertson M. M., Trimble M. R., Hill M. A., Benson D. F. Obsessions and compulsions in Gilles de la Tourette's syndrome. Neurology. 1986 Mar;36(3):378–382. doi: 10.1212/wnl.36.3.378. [DOI] [PubMed] [Google Scholar]
  10. Goldstein M., Battista A. F., Ohmoto T., Anagnoste B., Fuxe K. Tremor and involuntary movements in monkeys: effect of L-dopa and of a dopamine receptor stimulating agent. Science. 1973 Feb 23;179(4075):816–817. doi: 10.1126/science.179.4075.816. [DOI] [PubMed] [Google Scholar]
  11. Harcherik D. F., Leckman J. F., Detlor J., Cohen D. J. A new instrument for clinical studies of Tourette's syndrome. J Am Acad Child Psychiatry. 1984 Mar;23(2):153–160. doi: 10.1097/00004583-198403000-00006. [DOI] [PubMed] [Google Scholar]
  12. Klawans H. L., Falk D. K., Nausieda P. A., Weiner W. J. Gilles de la Tourette syndrome after long-term chlorpromazine therapy. Neurology. 1978 Oct;28(10):1064–1066. doi: 10.1212/wnl.28.10.1064. [DOI] [PubMed] [Google Scholar]
  13. Leckman J. F., Riddle M. A., Berrettini W. H., Anderson G. M., Hardin M., Chappell P., Bissette G., Nemeroff C. B., Goodman W. K., Cohen D. J. Elevated CSF dynorphin A [1-8] in Tourette's syndrome. Life Sci. 1988;43(24):2015–2023. doi: 10.1016/0024-3205(88)90575-9. [DOI] [PubMed] [Google Scholar]
  14. Leonard H. L., Rapoport J. L. Relief of obsessive-compulsive symptoms by LSD and psilocin. Am J Psychiatry. 1987 Sep;144(9):1239–1240. doi: 10.1176/ajp.144.9.1239b. [DOI] [PubMed] [Google Scholar]
  15. McDougle C. J., Goodman W. K., Delgado P. L., Price L. H. Pathophysiology of obsessive-compulsive disorder. Am J Psychiatry. 1989 Oct;146(10):1350–1351. doi: 10.1176/ajp.146.10.1350. [DOI] [PubMed] [Google Scholar]
  16. McDougle C. J., Goodman W. K., Price L. H., Delgado P. L., Krystal J. H., Charney D. S., Heninger G. R. Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder. Am J Psychiatry. 1990 May;147(5):652–654. doi: 10.1176/ajp.147.5.652. [DOI] [PubMed] [Google Scholar]
  17. Mesulam M. M. Cocaine and Tourette's syndrome. N Engl J Med. 1986 Aug 7;315(6):398–398. doi: 10.1056/NEJM198608073150617. [DOI] [PubMed] [Google Scholar]
  18. Moldofsky H., Tullis C., Lamon R. Multiple tic syndrome (Giles de la Tourette's syndrome). J Nerv Ment Dis. 1974 Oct;159(4):282–292. doi: 10.1097/00005053-197410000-00007. [DOI] [PubMed] [Google Scholar]
  19. Nee L. E., Caine E. D., Polinsky R. J., Eldridge R., Ebert M. H. Gilles de la Tourette syndrome: clinical and family study of 50 cases. Ann Neurol. 1980 Jan;7(1):41–49. doi: 10.1002/ana.410070109. [DOI] [PubMed] [Google Scholar]
  20. Pfaus J. G., Phillips A. G. Differential effects of dopamine receptor antagonists on the sexual behavior of male rats. Psychopharmacology (Berl) 1989;98(3):363–368. doi: 10.1007/BF00451688. [DOI] [PubMed] [Google Scholar]
  21. Pitman R. K. Animal models of compulsive behavior. Biol Psychiatry. 1989 Jun;26(2):189–198. doi: 10.1016/0006-3223(89)90022-x. [DOI] [PubMed] [Google Scholar]
  22. Pitman R. K., Green R. C., Jenike M. A., Mesulam M. M. Clinical comparison of Tourette's disorder and obsessive-compulsive disorder. Am J Psychiatry. 1987 Sep;144(9):1166–1171. doi: 10.1176/ajp.144.9.1166. [DOI] [PubMed] [Google Scholar]
  23. Post R. M. Cocaine psychoses: a continuum model. Am J Psychiatry. 1975 Mar;132(3):225–231. doi: 10.1176/ajp.132.3.225. [DOI] [PubMed] [Google Scholar]
  24. Quinn N. P., Toone B., Lang A. E., Marsden C. D., Parkes J. D. Dopa dose-dependent sexual deviation. Br J Psychiatry. 1983 Mar;142:296–298. doi: 10.1192/bjp.142.3.296. [DOI] [PubMed] [Google Scholar]
  25. Robertson M. M. The Gilles de la Tourette syndrome: the current status. Br J Psychiatry. 1989 Feb;154:147–169. doi: 10.1192/bjp.154.2.147. [DOI] [PubMed] [Google Scholar]
  26. Robertson M. M., Trimble M. R., Lees A. J. The psychopathology of the Gilles de la Tourette syndrome. A phenomenological analysis. Br J Psychiatry. 1988 Mar;152:383–390. doi: 10.1192/bjp.152.3.383. [DOI] [PubMed] [Google Scholar]
  27. Sandyk R., Kwo-on-Yuen P. F., Awerbuch G., Bamford C. R. Inappropriate sexual behavior and denervation supersensitivity of limbic and midbrain LHRH receptors in Tourette's syndrome. J Clin Psychopharmacol. 1988 Aug;8(4):295–296. doi: 10.1097/00004714-198808000-00025. [DOI] [PubMed] [Google Scholar]
  28. Shapiro E., Shapiro A. K., Fulop G., Hubbard M., Mandeli J., Nordlie J., Phillips R. A. Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry. 1989 Aug;46(8):722–730. doi: 10.1001/archpsyc.1989.01810080052006. [DOI] [PubMed] [Google Scholar]
  29. Shapiro S. K. Hypersexual behavior complicating levodopa (I-dopa) therapy. Minn Med. 1973 Jan;56(1):58–59. [PubMed] [Google Scholar]
  30. Singer H. S., Butler I. J., Tune L. E., Seifert W. E., Jr, Coyle J. T. Dopaminergic dsyfunction in Tourette syndrome. Ann Neurol. 1982 Oct;12(4):361–366. doi: 10.1002/ana.410120408. [DOI] [PubMed] [Google Scholar]
  31. Stefl M. E. Mental health needs associated with Tourette syndrome. Am J Public Health. 1984 Dec;74(12):1310–1313. doi: 10.2105/ajph.74.12.1310. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES